Nuchal translucency in pregnancies conceived after assisted reproduction technology

Current Opinion in Obstetrics and Gynecology

Volumn 18, Issue 3, 2006, Pages 319-324

  Hui, Pui Wah ^a,b   Lee, Chin Peng ^a   Tang, Mary Hoi Yin ^a   Ho, Pak Chung ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Assisted reproduction technology; In vitro fertilization; Intracytoplasmic sperm injection; Nuchal translucency

Indexed keywords

BIOCHEMICAL MARKER;

COLOR ULTRASOUND FLOWMETRY; CROWN RUMP LENGTH; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DISEASE MARKER; DIZYGOTIC TWINS; DOWN SYNDROME; EMBRYO TRANSFER; ETHNOLOGY; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FETUS MONITORING; GESTATIONAL AGE; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; MATERNAL SERUM; NUCHAL TRANSLUCENCY MEASUREMENT; OOCYTE DONATION; OVARY HYPERSTIMULATION; PATHOPHYSIOLOGY; PATIENT MONITORING; PLACENTA PREVIA; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REPRODUCIBILITY; REVIEW; SCREENING TEST; TWIN PREGNANCY; UMBILICAL CORD;

DOWN SYNDROME; FEMALE; HUMANS; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY, MULTIPLE; REPRODUCTIVE TECHNIQUES, ASSISTED; TWINS;

EID: 33744968845     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.gco.0000193005.42910.35     Document Type: Review

References (55)

1. Nicolaides KH, Azar G, Byrne D, et al. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first-trimester of pregnancy. BMJ 1992; 304:867-889.
2. Pandya PP, Goldberg H, Walton B, et al. The implementation of first-trimester scanning at 10-13 weeks' gestation and the measurement of fetal nuchal translucency thickness in two maternity units. Ultrasound Obstet Gynecol 1995; 5:20-25.
3. Taipale P, Hiilesmaa V, Salonen R, Ylostalo P. Increased nuchal translucency as a marker for fetal chromosomal defects. N Engl J Med 1997; 337:1654-1658.
4. Economides DL, Whitlow BJ, Kadir R, et al. First trimester sonographic detection of chromosomal abnormalities in an unselected population. Br J Obstet Gynaecol 1998; 105:58-62.
5. Pajkrt E, van Lith JMM, Mol BWJ, et al. Screening for Down's syndrome by fetal nuchal translucency measurement in a general obstetric population. Ultrasound Obstet Gynecol 1998; 12:163-169.
6. Snijders RJM, Noble P, Sebire N, et al. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation. Lancet 1998; 351:343-346.
7. Wald NJ, Rodeck C, Hackshaw AK, et al. SURUSS Research Group. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). Health Technol Assess 2003; 7:1-77.
8. Maymon R, Jauniaux E. Down's syndrome screening in pregnancies after assisted reproductive techniques: an update. Reprod Biomed 2002; 4:285-293.
9. Pandya PP. Nuchal Translucency Thickness. In: Nicolaides KH, Sebire NJ, Snijders JM, editors. The 11-14 Weeks Scan: The Diagnosis of Fetal Abnormalities. New York: Parthenon; 1999. pp. 14-29.
10. Whitlow BJ, Chatzipapas IK, Economides DL. The effect of fetal neck position on nuchal translucency measurement. Br J Obstet Gynaecol 1998; 105:872-876.
11. Herman A, Dreazen E, Samandarov A, et al. On-to-on versus on-to-out nuchal translucency measurements. Ultrasound Obstet Gynecol 2000; 15:126-130.
12. Schaefer M, Laurichesse-Delmas H, Ville Y. The effect of nuchal cord on nuchal translucency measurement at 10-14 weeks. Ultrasound Obstet Gynecol 1998; 11:271-273.
13. Braithwaite JM, Morris RW, Economides DL. Nuchal translucency measurements: frequency distribution and changes with gestation in a general population. Br J Obstet Gynaecol 1996; 103:1201-1204.
14. Hsu JJ, Hsieh CC, Chiang CH, et al. Preliminary normal reference values of nuchal translucency thickness in Taiwanese fetuses at 11-14 weeks of gestation. Chang Gung Med J 2003; 26:12-19.
15. Jou HJ, Wu SC, Li TC, et al. Relationship between fetal nuchal translucency and crown-rump length in an Asian population. Ultrasound Obstet Gynecol 2001; 17:111-114.
16. Schuchter K, Wald N, Hackshaw AK, et al. The distribution of nuchal translucency at 10-13 weeks of pregnancy. Prenat Diagn 1998; 18:281-286.
17. Chen M, Lam YH, Tang MH, et al. The effect of ethnic origin on nuchal translucency at 10-14 weeks of gestation. Prenat Diagn 2002; 22:576-578.
18. Lam YH, Tang MH, Lee CP, et al. The effect of fetal gender on nuchal translucency at 10-14 weeks of gestation. Prenat Diagn 2001; 21:627-629.
19. Larsen SO, Wojdemann KR, Shalmi AC, et al. Gender impact on first-trimester markers in Down syndrome screening. Prenat Diagn 2002; 22:1207-1208.
20. Spencer K, Ong CY, Liao AW, Nicolaides KH. The influence of parity and gravidity on first trimester markers of chromosomal abnormality. Prenat Diagn 2000; 20:792-794.
21. Maymon R, Dreazen E, Rozinsky S, et al. Comparison of nuchal translucency measurement and mid-gestation serum screening in assisted reproduction versus naturally conceived singleton pregnancies. Prenat Diagn 1999; 19:1007-1011.
22. Maymon R, Shulman A. Serial first- and second-trimester Down's syndrome screening tests among IVF- versus naturally-conceived singletons. Hum Reprod 2002; 17:1081-1085.
23. Maymon R, Shulman A. Integrated first- and second-trimester Down's syndrome screening test among unaffected IVF pregnancies. Prenat Diagn 2004; 24:125-129. The first paper reporting test performance with the integration of NT into screening for Down's syndrome in IVF pregnancies.
24. Wojdemann KR, Larsen SO, Shalmi A, et al. First trimester screening for Down syndrome and assisted reproduction: no basis for concern. Prenat Diagn 2001; 21:563-565.
25. Liao AW, Heath V, Kametas N, et al. First-trimester screening for trisomy 21 in singleton pregnancies achieved by assisted reproduction. Hum Reprod 2001; 16:1501-1504.
26. Orlandi F, Rossi C, Allegra A, et al. First trimester screening with free beta-hCG, PAPP-A and nuchal translucency in pregnancies conceived with assisted reproduction. Prenat Diagn 2002; 22:718-721.
27. Ghisoni L, Ferrazzi E, Castagna C, et al. Prenatal diagnosis after ART success: the role of early combined screening tests in counselling pregnant patients. Placenta 2003; 24:S99-S103.
28. Hui PW, Tang MHY, Lam YH, et al. Nuchal translucency in pregnancies conceived after assisted reproduction technology. Ultrasound Obstet Gynecol 2005; 25:234-238. A retrospective analysis of the variation in thickness of NT in pregnancies after different assisted-reproduction treatments, including pregnancies after ICSI and frozen embryo transfers.
29. Lai TH, Chen SC, Tsai MS, et al. First trimester screening for Down syndrome in singleton pregnancies achieved by intrauterine insemination. J Assist Reprod Genet 2003; 20:327-331.
30. Maymon R, Dreazen E, Tovbin Y, et al. The feasibility of nuchal translucency measurement in higher order multiple gestations achieved by assisted reproduction. Hum Reprod 1999; 14:2102-2105.
31. Maymon R, Jauniaux E, Holmes A, et al. Nuchal translucency measurement and pregnancy outcome after assisted conception versus spontaneously conceived twins. Hum Reprod 2001; 16:1999-2004.
32. Maymon R, Neeman O, Shulman A, et al. Current concepts of Down syndrome screening tests in assisted reproduction twin pregnancies: another double trouble. Prenat Diagn 2005; 25:746-750. A comprehensive review highlighting the current challenges related to biochemical screening for Down's syndrome and the potential use of the nuchal test in assisted-reproduction twin pregnancies.
33. Wenstrom KD, Syrop CH, Hammitt DG, Van Voorhis BJ. Increased risk of monochorionic twinning associated with assisted reproduction. Fertil Steril 1993; 60:510-514.
34. Sebire NJ, Snijders RJ, Hughes K, et al. Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation. Br J Obstet Gynaecol 1996; 103:999-1003.
35. Monni G, Zoppi MA, Ibba RM, et al. Nuchal translucency in multiple pregnancies. Croat Med J 2000; 41:266-269.
36. Sebire NJ, Souka A, Skentou H, et al. Early prediction of severe twin-to-twin transfusion syndrome. Hum Reprod 2000; 15:2008-2010.
37. Hui PW, Tang MHY, Ng EHY, et al. Nuchal translucency in dichorionic twins conceived after assisted reproduction. Prenat Diagn (in press).
38. Bohlandt S, von Kaisenberg CS, Wewetzer K, et al. Hyaluronan in the nuchal skin of chromosomally abnormal fetuses. Hum Reprod 2000; 15:1155-1158.
39. von Kaisenberg CS, Nicolaides KH, Brand-Saberi B. Lymphatic vessel hypoplasia in fetuses with Turner syndrome. Hum Reprod 1999; 14:823-826.
40. Haak MC, Bartelings MM, Jackson DG, et al. Increased nuchal translucency is associated with jugular lymphatic distension. Hum Reprod 2002; 17:1086-1092.
41. Montenegro N, Matias A, Areias JC, et al. Increased fetal nuchal translucency: possible involvement of early cardiac failure. Ultrasound Obstet Gynecol 1997; 10:265-268.
42. Haak MC, van Vugt JM. Pathophysiology of increased nuchal translucency: a review of the literature. Hum Reprod Update 2003; 9:175-184.
43. Lam YH, Yeung WS, Tang MH, et al. Maternal serum alpha-fetoprotein and human chorionic gonadotrophin in pregnancies conceived after intracytoplasmic sperm injection and conventional in-vitro fertilization. Hum Reprod 1999; 14:2120-2123.
44. Hui PW, Tang MH, Lam YH, et al. Maternal serum hCG and alpha-fetoprotein levels in pregnancies conceived after IVF or ICSI with fresh and frozen-thawed embryos. Hum Reprod 2003; 18:572-575.
45. Hui PW, Lam YH, Tang MHY, et al. Maternal serum pregnancy associated plasma protein-A and free β human chorionic gonadotrophin in pregnancies conceived with fresh and frozen-thawed embryos from in vitro fertilization and intracytoplasmic sperm injection. Prenat Diagn 2005; 25:390-393. This paper reports the variation in first-trimester biochemical markers in assisted-reproduction pregnancies.
46. Wald NJ, White N, Morris JK, et al. Serum markers for Down's syndrome in women who have had in vitro fertilisation: implications for antenatal screening. Br J Obstet Gynaecol 1999; 106:1304-1306.
47. Maymon R, Shulman A. Comparison of triple serum screening and pregnancy outcome in oocyte donation versus IVF pregnancies. Hum Reprod 2001; 16:691-695.
48. Muller F, Dreux S, Lemeur A, et al. French Collaborative Group. Medically assisted reproduction and second-trimester maternal serum marker screening for Down syndrome. Prenat Diagn 2003; 23:1073-1076.
49. Rice JD, McIntosh SF, Halstead AC. Second-trimester maternal serum screening for Down syndrome in in-vitro fertilization pregnancies. Prenat Diagn 2005; 25:234-238.
50. Bellver J, Lara C, Soares SR, et al. First trimester biochemical screening for Down's syndrome in singleton pregnancies conceived by assisted reproduction. Hum Reprod 2005; 20:2623-2627.
51. Maymon R, Herman A. The clinical evaluation and pregnancy outcome of euploid fetuses with increased nuchal translucency. Clin Genet 2004; 66:426-436. A comprehensive review of pregnancy outcomes in fetuses with thickened NT.
52. Souka AP, Von Kaisenberg CS, Hyett JA, et al. Increased nuchal translucency with normal karyotype. Am J Obstet Gynecol 2005; 192:1005-1021. A comprehensive review of the spectrum of adverse perinatal outcome, pregnancy complications, congenital abnormalities and syndromal diseases associated with increased NT.
53. Jackson RA, Gibson KA, Wu YW, Croughan MS. Perinatal outcomes in singletons following in vitro fertilization: a meta-analysis. Obstet Gynecol 2004; 103:551-563. A meta-analysis, including over 12 000 IVF singleton and 1.9 million spontaneous pregnancies, that reports an increased risk of adverse perinatal outcome in pregnancies arising from IVF.
54. Helmerhorst FM, Perquin DA, Donker D, Keirse MJ. Perinatal outcome of singletons and twins after assisted conception: a systematic review of controlled studies. BMJ 2004; 328:261-265. A systemic review of 17 studies in singletons and 17 studies in twins, concluding that singletons conceived from assisted reproduction have a worse perinatal outcome than their spontaneous counterparts, but that this observation is not seen in twin pregnancies.
55. Pinborg A, Loft A, Nyboe Andersen A. Neonatal outcome in a Danish national cohort of 8602 children born after in vitro fertilization or intracytoplasmic sperm injection: the role of twin pregnancy. Acta Obstet Gynecol Scand 2004; 83:1071-1078. A study comprising the largest cohort of twins to date that investigated neonatal outcome in pregnancies arising from ART. It also provides important information on the subgroup of dizygotic twins as a separate entity.